These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 8225726)

  • 1. Topical minoxidil therapy for androgenic alopecia in the Middle East. The Middle-Eastern Topical Minoxidil Study Group.
    Karam P
    Int J Dermatol; 1993 Oct; 32(10):763-6. PubMed ID: 8225726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of topical minoxidil therapy for androgenetic alopecia in women.
    Jacobs JP; Szpunar CA; Warner ML
    Int J Dermatol; 1993 Oct; 32(10):758-62. PubMed ID: 8225725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response study of topical minoxidil in male pattern alopecia.
    Shupack JL; Kassimir JJ; Thirumoorthy T; Reed ML; Jondreau L
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):673-6. PubMed ID: 3549801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.
    Berger RS; Fu JL; Smiles KA; Turner CB; Schnell BM; Werchowski KM; Lammers KM
    Br J Dermatol; 2003 Aug; 149(2):354-62. PubMed ID: 12932243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
    Olsen EA; Weiner MS
    J Am Acad Dermatol; 1987 Jul; 17(1):97-101. PubMed ID: 3301926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Australian trial of topical minoxidil and placebo in early male pattern baldness.
    Connors TJ; Cooke DE; De Launey WE; Downie M; Knudsen RG; Shumack S; Eggleston AS
    Australas J Dermatol; 1990; 31(1):17-25. PubMed ID: 2073205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
    Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
    Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical minoxidil therapy in hereditary androgenetic alopecia.
    De Villez RL
    Arch Dermatol; 1985 Feb; 121(2):197-202. PubMed ID: 3883902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
    Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
    J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.
    Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss.
    Lucky AW; Piacquadio DJ; Ditre CM; Dunlap F; Kantor I; Pandya AG; Savin RC; Tharp MD
    J Am Acad Dermatol; 2004 Apr; 50(4):541-53. PubMed ID: 15034503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical minoxidil for male pattern baldness.
    Storer JS; Brzuskiewicz J; Floyd H; Rice JC
    Am J Med Sci; 1986 May; 291(5):328-33. PubMed ID: 3518451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical minoxidil for androgenetic alopecia: optimizing the chance for success by appropriate patient selection.
    DeVillez RL
    Dermatologica; 1987; 175 Suppl 2():50-3. PubMed ID: 3691914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
    Suchonwanit P; Rojhirunsakool S; Khunkhet S
    Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of topical minoxidil in the treatment of male pattern baldness.
    Savin RC
    J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):696-704. PubMed ID: 3549804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
    Gassmueller J; Hoffmann R; Webster A
    Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical minoxidil in early male pattern baldness.
    Olsen EA; Weiner MS; Delong ER; Pinnell SR
    J Am Acad Dermatol; 1985 Aug; 13(2 Pt 1):185-92. PubMed ID: 3900155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical minoxidil therapy for hereditary male pattern alopecia.
    Roenigk HH; Pepper E; Kuruvilla S
    Cutis; 1987 Apr; 39(4):337-42. PubMed ID: 3556042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
    Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
    J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of 2% topical minoxidil in the management of male pattern baldness in Chinese.
    Kuan YZ; Chen SY; Chen MJ; Wang CN; Chan HL
    Changgeng Yi Xue Za Zhi; 1990 Jun; 13(2):96-103. PubMed ID: 2224611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.